×
Back to Agenda
Blockchain in Clinical Trials Demo: Truth or Dare
Session Chair(s)
Adama Ibrahim, MBA
Vice President, Digital Strategy and Change Management, Novo Nordisk, United Kingdom
Use blockchain to show the design and implementation of faster, less onerous user identification processes through permissioned access to a federated database pointing to a variety of traditionally siloed sources (inc. EMR, wearables, IoT etc).
Learning Objective : Describe how a blockchain-powered health wallet could support greater efficiencies across the clinical trial process.
Speaker(s)
Facilitator
Life Sciences Practice Lead, Global Business Strategy and Intelligence (GBSI) , IEEE-Standards Association, United States
Facilitator
Founder and Chief Executive Officer, ACOER and Ex-CDC, United States
Facilitator
Head of Integrated Clinical & Operational Analytics, Johnson & Johnson, United Kingdom
Blockchain
Founder and Chief Executive Officer, SAAVHA Inc., United States
Have an account?